Risk Assessment & Screening for Hereditary Ovarian Cancer

Series

101 views

Save

Unlock Exclusive Access

Save

This series offers an integrated exploration of ovarian tumors, covering genetics, imaging, tumor markers, screening strategies, and real-world diagnostic dilemmas through expert talks and panel discussions, to enhance evidence-based understanding and management of ovarian masses and cancer.

Join our WhatsApp Channel to get updates. (NOTE: The channel is initially on mute, simply click on the unmute icon to start receiving notifications).

Episodes

All

1. A Game of Shadows: Imaging of Ovarian masses

25m

Dr Mohit Shah demystifies imaging-driven evaluation of adnexal masses with O-RADS, IOTA, and tumor markers to refine hereditary ovarian cancer risk assessment and screening.

2. Genes and Ovaries

29m

Dr Divya Uchil reviews hereditary ovarian cancer risk assessment and screening: BRCA/Lynch testing, cascade counseling, CA-125/TVUS limits, and timing of risk-reducing BSO.

3. Biochemical Detectives: Tumour Markers in Ovarian Masses

21m

Dr Sampada Dessai decodes tumor markers (CA-125, HE4, ROMA) to triage ovarian masses and guide hereditary ovarian cancer screening, plus a panel on ovarian tumor dilemmas.

4. A Practical Overview: Current Status of Screening for Ovarian Cancer

49m

Dr Richa Bansal outlines evidence-based risk assessment and screening for hereditary ovarian cancer, covering BRCA testing, CA-125, TVUS, and risk-reducing salpingo-oophorectomy.

5. Panel Discussion on Ovarian Tumours : A Dilemma

43m

Dr Samar Gupte leads a panel on ovarian tumours, focusing on hereditary cancer risk assessment, screening (CA-125, TVS, O-RADS), and triage of adnexal masses for referral.

What's Included in Subscription

Become a member & get access to

▪️Exclusive content library ▪️Onference original series